These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33682184)

  • 1. Effect of non-recommended doses versus recommended doses of direct oral anticoagulants in atrial fibrillation patients: A meta-analysis.
    Liu X; Huang M; Ye C; Xiao X; Yan C
    Clin Cardiol; 2021 Apr; 44(4):472-480. PubMed ID: 33682184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct Oral Anticoagulants vs. Warfarin in Latin American Patients With Atrial Fibrillation: Evidence From Four
    Liu F; Wang Y; Luo J; Huang L; Zhu W; Yin K; Xue Z
    Front Cardiovasc Med; 2022; 9():841341. PubMed ID: 35310968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety of Under or Over-dosing of Direct Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-analysis of 148909 Patients From 10 Real-World Studies.
    Shen NN; Zhang C; Wang N; Wang JL; Gu ZC; Han H
    Front Pharmacol; 2021; 12():645479. PubMed ID: 33815125
    [No Abstract]   [Full Text] [Related]  

  • 4. An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation.
    Shen NN; Ferroni E; Amidei CB; Canova C; Peron V; Wang JL; Lin HW; Gu ZC
    Clin Appl Thromb Hemost; 2023; 29():10760296231179439. PubMed ID: 37264798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis.
    Zhang XL; Zhang XW; Wang TY; Wang HW; Chen Z; Xu B; Xu W
    Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e007971. PubMed ID: 34932377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonist (VKA) among patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Rujirachun P; Charoenngam N; Wattanachayakul P; Winijkul A; Owattanapanich W; Ungprasert P
    Acta Cardiol; 2020 Dec; 75(8):724-731. PubMed ID: 31558097
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta-analysis of observational studies.
    Guo Z; Ding X; Ye Z; Chen W; Chen Y
    Clin Cardiol; 2021 Jul; 44(7):917-924. PubMed ID: 34013988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
    Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
    CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Direct Oral Anticoagulants (DOACs) Versus Warfarin in Atrial Fibrillation Patients with Prior Stroke: a Systematic Review and Meta-analysis.
    Umashankar K; Mammi M; Badawoud E; Tang Y; Zhou M; Borges JC; Liew A; Migliore M; Mekary RA
    Cardiovasc Drugs Ther; 2023 Dec; 37(6):1225-1237. PubMed ID: 35467313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis.
    Hu T; Li YH; Han WQ; Maduray K; Chen TS; Hao L; Zhong JQ
    Am J Cardiovasc Drugs; 2023 Nov; 23(6):683-694. PubMed ID: 37639201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.
    Caso V; de Groot JR; Sanmartin Fernandez M; Segura T; Blomström-Lundqvist C; Hargroves D; Antoniou S; Williams H; Worsley A; Harris J; Caleyachetty A; Vardar B; Field P; Ruff CT
    Heart; 2023 Jan; 109(3):178-185. PubMed ID: 36316100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Direct Oral Anticoagulants in Patients with Diabetes and Nonvalvular Atrial Fibrillation: Meta-Analysis of Observational Studies.
    Cao B; Yao X; Zhang L; Hu X; Chen M; Shen M; Xu L
    Cardiovasc Ther; 2021; 2021():5520027. PubMed ID: 34729079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis.
    Gao X; Huang D; Hu Y; Chen Y; Zhang H; Liu F; Luo J
    Front Cardiovasc Med; 2022; 9():833329. PubMed ID: 35615562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.
    Camm AJ; Cools F; Virdone S; Bassand JP; Fitzmaurice DA; Arthur Fox KA; Goldhaber SZ; Goto S; Haas S; Mantovani LG; Kayani G; Grierson Turpie AG; Antoon Verheugt FW; Kakkar AK;
    J Am Coll Cardiol; 2020 Sep; 76(12):1425-1436. PubMed ID: 32943160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct oral anticoagulants for stroke prevention in atrial fibrillation: treatment outcomes and dosing in special populations.
    Stacy ZA; Richter SK
    Ther Adv Cardiovasc Dis; 2018 Sep; 12(9):247-262. PubMed ID: 30081727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis of Observational Studies.
    Douros A; Durand M; Doyle CM; Yoon S; Reynier P; Filion KB
    Drug Saf; 2019 Oct; 42(10):1135-1148. PubMed ID: 31175610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis.
    Mosconi MG; Maraziti G; Paciaroni M; Giustozzi M; Vedovati MC; Bogliari G; Urbini C; Traballi L; Caso V
    Eur Neurol; 2023; 86(1):13-24. PubMed ID: 36099877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses.
    Briasoulis A; Gao Y; Inampudi C; Alvarez P; Asleh R; Chrischilles E; Leira EC; Vaughan-Sarrazin M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):42. PubMed ID: 32013886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study.
    Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V
    Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.